Fit Older Adults with Advanced Myelodysplastic Syndromes: Who is Most Likely to Benefit from Transplant?

We conducted a prospective observational study of fit adults aged 60 to 75 with advanced MDS, enrolled hierarchically for adverse MDS risk (intermediate-2 or high-risk international prognostic score [IPSS], low or intermediate-1 IPSS with poor-risk cytogenetics, or therapy-related MDS) or standard r...

Descripción completa

Detalles Bibliográficos
Autores principales: Abel, Gregory A., Kim, Haesook T., Hantel, Andrew, Steensma, David P., Stone, Richard, Habib, Anand, Ho, Vincent T., Wadleigh, Martha, El-Jawahri, Areej, Alyea, Edwin P., DeAngelo, Daniel, Koreth, John, Antin, Joseph H., Soiffer, Robert J., Cutler, Corey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035144/
https://www.ncbi.nlm.nih.gov/pubmed/33204012
http://dx.doi.org/10.1038/s41375-020-01092-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035144/
https://www.ncbi.nlm.nih.gov/pubmed/33204012
http://dx.doi.org/10.1038/s41375-020-01092-2

Ejemplares similares